X

pharmaceuticals

Aurobindo Pharma Q4 FY 2022 Research Tear Sheet

Aurobindo Pharma Limited is an Indian pharmaceutical company. It was established in the year 1986. The founders include Mr. P.V.…

Aurobindo Pharma Limited Q4 FY22 Earnings Conference Call Insights

https://youtu.be/ZZNGEHlRimc Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q4 FY22 Earnings Concall Management Update: AUROPHARMA received final approval for 3…

Hikal Limited Q4 FY22 Earnings Conference Call Insights

https://youtu.be/3z2q_SR1OS4 Key highlights from Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Management Update: HIKAL said its new product launches in…

Glenmark Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights

https://youtu.be/uTUQ9VpSoiU Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY22 Earnings Concall Management Update: GLENMARK said the India business continues…

Aurobindo Pharma Ltd (AUROPHARMA) Q4 FY22 Earnings Concall Transcript

Aurobindo Pharma Ltd (NSE: AUROPHARMA) Q4 FY22 Earnings Concall dated May 30, 2022 Corporate Participants: Deepthi Thakur -- Investor Relations Santhanam Subramanian -- Chief…

Piramal Enterprises Ltd Q4 FY22 Earnings Conference Call Insights

Key highlights from Piramal Enterprises Ltd (PEL) Q4 FY22 Earnings Concall Management Update: Over the next five years, PEL aspire…

Torrent Pharmaceuticals Ltd Q4 FY22 Earnings Conference Call Insights

Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal of Credit Suisse asked about…

Supriya Lifescience Ltd Q4 FY22 Earnings Conference Call Insights

https://youtu.be/VIL70Aj2g04 Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q4 FY22 Earnings Concall Management Update: SUPRIYA said that going forward the…

Divi’s Laboratories Ltd Q4 FY22 Earnings Conference Call Insights

https://youtu.be/MLu1npKFqZg Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY22 Earnings Concall Management Update: DIVISLAB said it reached milestone revenue…

Dr. Reddy’s Laboratories (DRREDDY) Q4 FY22 Earnings Concall Transcript

Dr. Reddy's Laboratories (NSE: DRREDDY) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Amit Agarwal -- Head of Investor Relations…